INS and type 1 diabetes mellitus: Treating human islet cells with IFN-α in vitro triggers endoplasmic reticulum stress which disrupts insulin production by hindering the conversion of proinsulin to insulin signifying a potential mechanism by which IFN-α may be prompting development of T1D (77).